Medindia

X

Centene Corporation to Present at Goldman Sachs 2011 Global Healthcare Conference

Friday, May 27, 2011 General News J E 4
Advertisement

ST. LOUIS, May 26, 2011 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced it will present at the Goldman Sachs 32nd Annual Global Healthcare Conference, to be held June 7-9, 2011, at the Terranea Resort in Los Angeles, Calif.

Centene's presentation is scheduled for Tuesday, June 7th at 4:00 p.m. Pacific Time. A live audio webcast of the presentation will be available via the following link: http://cc.talkpoint.com/gold006/060711a_lr/?entity=56_0MG5L5C.

Shortly after the presentation, a webcast replay will be available via the Company's website at www.centene.com under the Investors section.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care, long-term care, other state-sponsored programs and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique "exchange-based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management. More information regarding Centene is available at www.centene.com.

SOURCE Centene Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
MAP Pharmaceuticals Submits New Drug Application t...
S
Statement From Volcano Corporation on Latest St. J...